References

1. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364(9442): 1343-1360. Review.

2. Ashley-Koch A, Yang Q, Olney RS. Sickle hemoglobin (HbS) allele and sickle cell disease: A huge review. Am J Epidemiol 2000;151: 839-844.

3. Steinberg MH. Pathophysiologically based drug treatment of sickle cell disease. Trends Pharmacol Sci 2006;27(4):204-210.

4. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004;103(11):4023-4027.

5. National Institutes of Health. The Management of Sickle Cell Disease. NIH Pub. No. 02-2117. Bethesda, MD, Division of Blood Diseases and Resources, Public Health Service, U.S. Department of Health and Human Services, June 2002:1-88.

6. World Health Organization Fifty-Ninth World Health Assembly 2006. Available at http://www.who.int/gb/ebwha/pdf_files/WHA59/A59_9-en.pdf.

7. Lanzkowsky P. Manual of Pediatric Hematology and Oncology, 4th ed. New York: Churchill Livingstone, 2005:160.

8. Rosse WF, Narla M, Petz LD, Steinberg MH. New views of sickle cell disease pathophysiology and treatment. Hematology Am Soc Hematol Educ Program 2000;2000:2-17.

9. Sickle Cell Disease Care Consortium. Sickle Cell Disease in Children and Adolescents: Diagnosis, Guidelines for Comprehensive Care, and Care Paths and Protocols for Management of Acute and Chronic Complications, November 2001. ht-tp://www. scinfo.org/Protocol-2002.PDF.

10. American Academy of Pediatrics Committee on Infectious Diseases. Recommended childhood and adolescent immunization schedule—United States, 2009. Pediatrics 2009;123:189-190.

11. Committee on Infectious Diseases, American Academy of Pediatrics. Policy Statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000;106:362-366.

12. Adamkiewicz TV, Sarnaik S, Buchanan GR, et al. Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr 2003;143:438-444.

13. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330(23):1639-1644.

14. Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000;342:83-89.

15. Advisory Committee on Immunization Practices, CDC. Preventing pneumococcal disease among infants and young children. Morb Mortal Wkly Rep 2000;49:1-38.

16. Falletta JM, Woods RM, Verter JI, et al. Discontinuing penicillin prophylaxis in children with sickle cell anemia. J Pediatr 1995;127: 685-690.

17. Riddington C, Owusu-Ofori S. Prophylactic antibiotics for preventing pneumo-coccal infections in children with sickle cell disease. Cochrane Database 2002;(3):CD003427.

18. Kennedy TS, Fung EB, Kawchak DA, et al. Red blood cell folate and serum B12 status in children with sickle cell disease. J Pediatr Hematol Oncol 2001;23:165-169.

19. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995;332:1317-1322.

20. Steinberg MH, Bartin F, Castro O, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia. Risks and benefits up to 9 years of treatment. JAMA 2003;289:1645-1651.

21. Kinney TR, Helms RW, O'Branski EE, Ohene-Frempong K, et al. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 1999;94(5):1550-1554.

22. Zimmerman SA, Schultz WH, Davis JS, et al. Sustained long-term hematological efficacy of hydroxyurea at maximal tolerated dose in children with sickle cell disease. Blood 2004;103:2039-2045.

23. Hankins JS Ware RE, Rogers ZR, et al. Long-term hydroxyurea therapy for infants with sickle cell anemia: The HUSOFT extension study. Blood 2005;106:2269-2275.

24. Wilson S. Acute leukemia in a patient with sickle cell anemia treated with hydroxyurea (letter). Ann Intern Med 2000;133:925-926.

TM TM

25. Hydroxyurea monograph. Lexi-Comp Online , Pediatric Lexi-Drugs Online ,

Hudson, Ohio: Lexi-Comp, inc.; 2008; September 29, 2008.

26. Deferoxamine monograph. Lexi-Comp Online , Pediatric Lexi-Drugs Online ,

Hudson, Ohio: Lexi-Comp, September 29, 2008.

27. Deferasirox monograph. Lexi-Comp Online , Pediatric Lexi-Drugs Online ,

Hudson, Ohio: Lexi-Comp, September 29, 2008.

28. Decitabine monograph. Lexi-Comp Online , Lexi-Drugs Online , Hudson,

Ohio: Lexi-Comp, September 29, 2008.

29. Folic acid monograph. Lexi-Comp Online , Lexi-Drugs Online , Hudson, Ohio:

Lexi-Comp, September 29, 2008.

30. Aronoff GR, Bennett WM, Berns JS, et al., eds. Drug Prescribing in Renal Failure, 15th ed. Philadelphia: American College of Physicians; 2007.

31. Koshy M, Dorn L, Bressler L, et al. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia. Blood 2000;248:378-381.

32. Porter J, Vinchinsky E, Rose C, et al. A Phase II study with ICL670 (Exjade), a once-daily oral iron chelator, in patients with various transfusion dependent anemias and iron overload (abstract). Blood 2004;104:3193.

33. Piga A, Galanello R, Foschini ML, et al. Once-daily treatment with the oral iron chelator ICL670 (Exjade): results of a Phase II study in pediatric patients with A-thalassemia major (abstract). Blood 2004;104:3614.

Atkins RC, Walters MC. Haematopoietic cell transplantation in the treatment of sickle cell disease. Expert Opin Biol Ther 2003;3: 1215-1224.

Walters MC. Novel therapeutic approaches in sickle cell disease: Stem cell transplantation for sickle cell disease: How and when to intervene? Hematology Am Soc Hematol Educ Program 2002;22-29.

Adams RJ, Mckie VC, Bramilla D, Carl E, Gallagher D, Nichols FT, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials 1998;19:110-129.

Vichinsky E. Novel therapeutic approaches in sickle cell disease: Understanding the pathophysiology and treatment of pulmonary injury in sickle cell disease. Hematology Am Soc Hematol Edu Program 2002;16-22.

Knight-Madden J, Hambleton I. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev 2003;3:CD003733.

Sullivan KJ, Goodwin SR, Evangelist J, et al. Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Crit Care Med 1999;27:2563-2568.

Mantadakis E, Ewalt DH, Cavender JD et al. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood 2000;95:78-82.

Shantha TR, Finnerty DP, Rodriguez AP. Treatment of persistent penile erection and priapism using terbutaline. J Urol 1989;1427-1429.

Govier FE, Jonsson E, Kramer-Levien D. Oral terbutaline for the treatment of priapism. J Urol 1994:151:878-879.

Owusu-Ofori S, Riddington C. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell disease. Cochrane Database of Systematic Reviews 2002;(4):CD003425.

AAP Committee on Drugs. APAP Toxicity in children. Peds 2001;108(1):1020-1024.

Jacob E, Miaskowski C, Savedra M, et al. Management of vaso-occlusive pain in children with sickle cell disease. J Pediatr Hematol Oncol 2003;25:307-311.

Berde CB, Sethna NF. Analgesics for the treatment of pain in children. N Engl J Med 2002;347(14):1094.

Stinson J, Naser B. Pain management in children with sickle cell disease. Paediatr Drugs 2003;5:229-238.

48. Yale SH. Approach to the vaso-occlusive crisis in adults with sickle cell disease. Am Fam Physician 2000;61:1349-1356, 1363-1364.

49. Maxwell LG, Kaufmann SC, Bitzer S, et al. The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: A double-blind, prospective, randomized, controlled study. Anesth Analg 2005;100:953-958.

SECTION 15 DISEASES OF INFECTIOUS

ORIGIN

Anxiety and Depression 101

Anxiety and Depression 101

Everything you ever wanted to know about. We have been discussing depression and anxiety and how different information that is out on the market only seems to target one particular cure for these two common conditions that seem to walk hand in hand.

Get My Free Ebook


Post a comment